Cargando…

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients

Detalles Bibliográficos
Autores principales:	Kumar, Alok, Khrime, Dorchhom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839569/ https://www.ncbi.nlm.nih.gov/pubmed/33519350 http://dx.doi.org/10.4103/sjmms.sjmms_495_20

Ejemplares similares

Tacrolimus-induced mania in a patient with nephrotic syndrome
por: Kumar, Alok, et al.
Publicado: (2020)

Efficacy and Safety of Azilsartan Medoxomil and Telmisartan in Hypertensive Patients: A Randomized, Assessor-Blinded Study
por: Garg, Megha, et al.
Publicado: (2020)

Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial
por: Dash, Ashish, et al.
Publicado: (2023)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Saha, Lekha
Publicado: (2011)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
por: Juhasz, Attila, et al.
Publicado: (2018)

Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension
por: Iwashima, Yoshio, et al.
Publicado: (2023)

Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus
por: Meher, Bikash R, et al.
Publicado: (2022)

Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial
por: Naruse, Mitsuhide, et al.
Publicado: (2019)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension: A protocol of a network meta-analysis
por: Zhang, Yan, et al.
Publicado: (2019)

Safety, Tolerability, and Efficacy of Azilsartan Medoxomil With or Without Chlorthalidone During and After 8 Months of Treatment for Hypertension
por: Kipnes, Mark S., et al.
Publicado: (2015)

Azilsartan: Current Evidence and Perspectives in Management of Hypertension
por: Pradhan, Akshyaya, et al.
Publicado: (2019)

Critical evaluation of the efficacy and tolerability of azilsartan
por: De Caterina, Alberto R, et al.
Publicado: (2012)

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
por: Weber, Michael A, et al.
Publicado: (2018)

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2021)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine
por: Motozato, Kota, et al.
Publicado: (2016)

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2022)

Long term effect of telmisartan in HIV-positive male patients with high blood pressure
por: Ucciferri, Claudio, et al.
Publicado: (2015)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
por: Billecke, Scott S, et al.
Publicado: (2013)

Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension
por: Weber, Michael A., et al.
Publicado: (2014)

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults
por: Webb, Nicholas J. A., et al.
Publicado: (2016)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
por: Akat, Pramod B., et al.
Publicado: (2010)

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study
por: Rakugi, Hiromi, et al.
Publicado: (2012)

Severe angioedema of laryngeal inlet in a woman receiving telmisartan therapy undergoing breast conservation surgery
por: Behera, Bikram Kishore, et al.
Publicado: (2018)

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension
por: Johnson, Wallace, et al.
Publicado: (2017)

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
por: Volpe, Massimo, et al.
Publicado: (2012)

Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
por: Angeloni, Emiliano
Publicado: (2016)

Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study
por: Handley, Alison, et al.
Publicado: (2016)

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014)

Clinical data analysis of telmisartan for hypertension management in Indian population
por: Prem Kumar, A, et al.
Publicado: (2021)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia
por: Deerochanawong, Chaicharn, et al.
Publicado: (2022)

Improvement of Diurnal Blood Pressure Variation by Azilsartan
por: Okamura, Keisuke, et al.
Publicado: (2018)

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
por: Gitt, Anselm K, et al.
Publicado: (2013)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Hypertension and microalbuminuria in HIV infected patients: beneficial effects of the treatment with telmisartan
por: Ucciferri, Claudio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ls99ej7egq2crfjcn4nlg8p0co